NDAORALTABLET, EXTENDED RELEASE
Approved
Jun 2022
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
20
Clinical Trials (5)
Switching From SSRI to Desvenlafaxine on Cognitive Functioning
Started Apr 2018
36 enrolled
Major Depressive Disorder
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Started Nov 2017
59 enrolled
Hot FlashesBreast Neoplasms
Desvenlafaxine in Opioid-Dependent Patients
Started Jul 2014
18 enrolled
DepressionOpioid DependenceMethadone Treatment
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
Started Feb 2012
59 enrolled
Dysthymic DisorderDysthymiaChronic Depressive Disorder
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Started Jan 2012
50 enrolled
Major Depressive Disorder
Loss of Exclusivity
LOE Date
May 16, 2028
26 months away
Patent Expiry
May 16, 2028
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 7776358 | May 16, 2028 | Product | — |